Buspirona, o primeiro ansiolítico de segunda geraçäo

Korolkovas, Andrejus; Haraguchi, Toshio.
RBM rev. bras. med ; 46(9): 429-30, 432, 43, passim, set. 1989. ilus, tab
Artículo en Portugués | LILACS | ID: lil-80161

Documentos relacionados

  1. Serotonin regulation of intermittent and continuous alcohol drinking in male and female C57BL/6J mice with systemic SB242084 and buspirone.
  2. Buspirone: an update on a unique anxiolytic agent.
  3. Azapirones for Attention Deficit Hyperactivity Disorder: A Systematic Review.
  4. Buspirone for functional improvement after acute traumatic spinal cord injury: a propensity score-matched cohort study.
  5. Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases.
  6. Usefulness of Therapeutic Drug Monitoring and Pharmacogenetics for a Patient Treated with Olanzapine, Buspirone, and Fluvoxamine: A Case Study.
  7. Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.
  8. Disruption of Epithalamic Left-Right Asymmetry Increases Anxiety in Zebrafish.
  9. Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
  10. Opposing effects of 5-HT1A receptor agonist buspirone on supraspinal abdominal pain transmission in normal and visceral hypersensitive rats.